|
|
{{if listFind(vars.channel_names, "MSIF News")}} {{endif}}  {{if listFind(vars.channel_names, "MSIF News")}} {{endif}} {{if listFind(vars.channel_names, "MSIF News")}} 
MSIF News
{{endif}}
|
{{if listFind(vars.channel_names, "People With MS News")}} {{endif}}  {{if listFind(vars.channel_names, "People With MS News")}} {{endif}} {{if listFind(vars.channel_names, "People With MS News")}} 
People with MS News
{{endif}}
|
{{if listFind(vars.channel_names, "Research News")}} {{endif}}  {{if listFind(vars.channel_names, "Research News")}} {{endif}} {{if listFind(vars.channel_names, "Research News")}} 
Research News
{{endif}}
|
{{if listFind(vars.channel_names, "MS Society News")}} {{endif}}  {{if listFind(vars.channel_names, "MS Society News")}} {{endif}} {{if listFind(vars.channel_names, "MS Society News")}} 
MS News
{{endif}}
|
|
|
|
Making Connections
German-language Principles to Promote the Quality of Life of People with MS is available to download
MSIF is delighted to announce that the professionally designed German-language version of the Principles to Promote the Quality of Life of People with Multiple Sclerosis is now available to be downloaded from our World of MS website.
To read more about the Principles and how they are helping people with MS, click here. To download a copy of the German translation, please click here.
|
{{if listFind(vars.channel_names, "MSIF News")}}
|
|
MSIF News
 |
 |
| Summaries of new MSIF activities, events, projects, programmes, resources, publications and more. |
Atlas of Multiple Sclerosis poster at ECTRIMS
MSIF is delighted that the joint MSIF/World Health Organization abstract, Atlas of MS, has been accepted as a poster at the 22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), taking place in Madrid, 27-30 September 2006.
read more
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "People With MS News")}}
|
|
People with MS News
 |
 |
| Summaries of news, views and achievements from people with MS around the world. |
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "Research News")}}
|
|
Research News
 |
 |
| Summaries of all the latest research findings on MS selected by a team based at the Institute of Neurology, London. |
|
|
|
|
{{endif}}
{{if listFind(vars.channel_names, "MS Society News")}}
|
|
MS News
 |
 |
| Summaries of MS news from websites around the world. |
Tysabri® available soon in US
source: US National MS Society
Companies launch the marketing of Tysabri® for relapsing MS, making the drug available for people in the US in the coming weeks.
read more
New findings on Copaxone
source: US National MS Society
Researchers have found a new explanation for the effects of Copaxone® (glatiramer acetate, Teva Pharmaceuticals), a treatment approved for relapsing-remitting multiple sclerosis.
read more
|
{{endif}}
|
|
Tell a friend

The email you subscribed with us is {{print email}}
Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.
If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.
If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here
Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org
|
|